Topical Pain Relief: Package Insert and Label Information
TOPICAL PAIN RELIEF- trolamine salicylate cream
CBH International
Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
Active Ingredient
Trolamine salicylate 10%
Purpose
Antiacne medication
Uses
Temporary releif of minor aches and pains of musclesand joints associated with simple backache, arthritis, strains, bruises and sprains.
Warnings
For external use only
When using this product
Avoid contact with eyes
Do not apply to wounds or damaged skin
Do not bandage tightly
Stop use and ask a doctor if
Conditons worsen
Symptoms persist for more than 7 days or clear up and occur again withina few days
Keep out of reach of children
If swallowed, get medical help or contact a Poison Control Center right away.
Directions
Adults and children 2 years of age and older: Apply to affected area not more than 3 to 4 times daily.
Children under 2 years of age: Consult a doctor.
Other Information
Store at room temperature. Avoid excessive heat.
Inactive Ingredients
Beeswax, Cannabis Sativa Seed Oil, Carthamus Tinctorius (Safflower) Seed Oil, Cetearyl Olivate, Cocos Nucifera (Coconut) Oil, Emu Oil, Fragrance, Tocopherol
TOPICAL PAIN RELIEF trolamine salicylate cream cream | ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
|
Labeler — CBH International (116834275) |
Establishment | |||
Name | Address | ID/FEI | Operations |
TAKA USA, Inc. dba Cosmetic Innovations | 802860515 | manufacture (72680-001), analysis (72680-001) |
Revised: 01/2021 CBH International
DrugInserts.com provides trustworthy package insert and label information about marketed drugs as submitted by manufacturers to the US Food and Drug Administration. Package information is not reviewed or updated separately by DrugInserts.com. Every individual package label entry contains a unique identifier which can be used to secure further details directly from the US National Institutes of Health and/or the FDA.